EU research project MS Fatigue_Therapy has begun by using multiple methodologies to gauge the effectiveness of hippotherapy for the treatment of multiple sclerosis (MS) fatigue and other daily disabilities in MS patients.
Diagnosed in over 2.3 million people, MS is the most common debilitating disease in young adults worldwide. There are over 120 000 diagnosed cases in Germany alone. Great strides have been made in developing medications that slow disease progression. However, its daily symptoms remain largely untreated.
Further details: Hippotherapy for MS fatigue: not horseplay at all